Frequency News and Research

RSS

Targacept initiates TC-5214 Phase 2b clinical study in patients with OAB

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of a Phase 2b clinical study of TC-5214 as a treatment for overactive bladder.

29 May 2013

Perrigo receives final approval for generic Sanctura XR

Perrigo Company today announced that it has received final approval for the generic version of Sanctura XR. Perrigo had previously prevailed in litigation at both the district and appellate levels. The product has begun shipping immediately.

29 May 2013

FDA approves iTrace for Blood Centers to assist in enhancing blood safety

iTrace for Blood Centers, (Version 1.0.924.0), the first application to use Radio Frequency Identification technology in blood establishments to assist in enhancing blood safety by preventing the release of unsuitable blood components, was cleared today by the U.S. Food and Drug Administration.

29 May 2013

Medical researchers identify genetic marker associated with sporadic breast cancer

Medical researchers at the University of Alberta have pinpointed a genetic marker for sporadic breast cancer - one of a handful identified to date in Caucasians.

29 May 2013

Physicists develop novel technique that can detect molecular variants

Harvard physicists have developed a novel technique that can detect molecular variants in chemical mixtures - greatly simplifying a process that is one of the most important, though time-consuming, processes in analytical chemistry.

23 May 2013

$Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS$

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

Upsher-Smith Laboratories, Inc. today announced the successful completion of its global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary formulation technology.

23 May 2013

MemorialCare Health System receives 2013 Crimson Physician Partnership Award

MemorialCare Health System is one of two organizations chosen from more than 1,000 hospitals nationwide to receive the prestigious 2013 Crimson Physician Partnership Award presented by The Advisory Board at its Scottsdale, Arizona Summit.

22 May 2013

AIR2 trial: Alair BT System shows therapy benefits in adults with severe uncontrolled asthma

Five-year data from the Asthma Intervention Research 2 clinical trial presented today demonstrated that the Boston Scientific Corporation Alair Bronchial Thermoplasty System continues to show therapy benefits in adult patients with severe uncontrolled asthma.

22 May 2013

COPD patients are more oliley to suffre from depression

Patients suffering from chronic obstructive pulmonary disease (COPD) typically suffer from depression more frequently than those without COPD, resulting in higher levels of disability and illness and increasing the overall healthcare burden for the COPD population.

21 May 2013

Research: Frequency of candy consumption is not associated with adverse health risks

At a time when the spotlight is focused on obesity more than ever, new research suggests that frequency of candy consumption is not associated with weight or certain adverse health risks.

21 May 2013

New research suggests that listening to music lowers anxiety, sedation in ventilated patients

New research suggests that for some hospitalized ICU patients on mechanical ventilators, using headphones to listen to their favorite types of music could lower anxiety and reduce their need for sedative medications.

21 May 2013

Blind people have potential to use echolocation to locate objects, new research shows

New research from the University of Southampton has shown that blind and visually impaired people have the potential to use echolocation, similar to that used by bats and dolphins, to determine the location of an object.

21 May 2013

People exposed to wood and tobacco smoke are at greater risk for developing COPD

People who are consistently exposed to both wood smoke and tobacco smoke are at a greater risk for developing chronic obstructive pulmonary disease and for experiencing more frequent and severe symptoms of the disease, as well as more severe airflow obstruction, than those who are exposed to only one type of smoke, according to the results of a new population-based study conducted by researchers in Colombia.

21 May 2013

Peripherally inserted central catheters increase risk of dangerous blood clots

Touted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications.

20 May 2013

Research highlights benefits of vitamin D, diet changes in patients with Crohn's disease

Research presented at Digestive Disease Week explores new methods for managing digestive health through diet and lifestyle.

20 May 2013

Research reveals that US children experience gastrointestinal issues

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week.

20 May 2013

Boston Scientific presents data on breakthrough products at Digestive Disease Week 2013

Boston Scientific Corporation is scheduled to participate in Digestive Disease Week 2013, May 18-21 in Orlando, Fla.

20 May 2013

Humans: The primary cause of global climate change

Do most scientists agree that human activity is causing global climate change? Yes, they do, according to an extensive analysis of the abstracts or summaries of scientific papers published over the past 20 years, even though public perception tends to be that climate scientists disagree over the fundamental cause of climate change.

17 May 2013

GE Healthcare introduces novel MR imaging technology

At an event held today at Hospital for Special Surgery, GE Healthcare introduced MAVRIC SL, a novel magnetic resonance imaging technique designed to address the growing clinical need to more accurately image soft tissue and bone in patients with MR Conditional-labeled implants, such as joint replacements and other instrumentation.

16 May 2013

Simponi injection gets FDA approval to treat adults with ulcerative colitis

The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.

16 May 2013

Frequency News and Research

Targacept initiates TC-5214 Phase 2b clinical study in patients with OAB

Perrigo receives final approval for generic Sanctura XR

FDA approves iTrace for Blood Centers to assist in enhancing blood safety

Medical researchers identify genetic marker associated with sporadic breast cancer

Physicists develop novel technique that can detect molecular variants

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

MemorialCare Health System receives 2013 Crimson Physician Partnership Award

AIR2 trial: Alair BT System shows therapy benefits in adults with severe uncontrolled asthma

COPD patients are more oliley to suffre from depression

Research: Frequency of candy consumption is not associated with adverse health risks

New research suggests that listening to music lowers anxiety, sedation in ventilated patients

Blind people have potential to use echolocation to locate objects, new research shows

People exposed to wood and tobacco smoke are at greater risk for developing COPD

Peripherally inserted central catheters increase risk of dangerous blood clots

Research highlights benefits of vitamin D, diet changes in patients with Crohn's disease

Research reveals that US children experience gastrointestinal issues

Boston Scientific presents data on breakthrough products at Digestive Disease Week 2013

Humans: The primary cause of global climate change

GE Healthcare introduces novel MR imaging technology

Simponi injection gets FDA approval to treat adults with ulcerative colitis

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News